人类心脏病中的潜在心肌细胞再生
Wouter Derks1, Julian Rode2, Sofia Collin3
1Centers for Regenerative Therapies Dresden (W.D., F.R., P.H., A.H., L.P., I.S., O.B.), Technische Universität Dresden, Germany.
Circulation
|November 21, 2024
概括
人类心力衰竭患者心肌细胞的更新有限. 然而,左心室辅助装置显著促进心脏细胞再生,为心脏病提供治疗潜力.
科学领域:
- 心脏病学
- 复原医学
- 分子生物学
背景情况:
- 成年人心肌细胞具有有限的再生能力,每年更新率约为0.5%.
- 在人类心力衰竭的背景下,这种心肌细胞再生能力的利用程度仍然是争议的话题.
研究的目的:
- 在患有晚期心力衰竭的患者中研究和量化心肌细胞更新率.
- 评估左心室辅助装置 (LVAD) 对心肌细胞再生的影响.
主要方法:
- 分析52名晚期心力衰竭患者的心肌细胞更新,其中28名接受了LVAD支持.
- 在心肌细胞基因组DNA中测量14C度,使用炸弹测试衍生的同位素.
- 运用数学建模来确定心肌细胞更新率在心力衰竭中,有或没有LVAD卸载.
主要成果:
- 在末期心力衰竭患者中,心肌细胞的产生是最小的,发生率比健康患者低18至50倍.
- 用LVAD支持治疗的患者表现出显著的功能和结构性心脏改善.
- 在接受LVAD治疗的患者中,与健康的心脏基线相比,心肌细胞更新的显著增加超过6倍.
结论:
- 人类心脏病,特别是心力衰竭,具有相当大的,但以前被低估的心肌细胞再生潜力.
- 这些发现表明心肌细胞在心力衰竭中的再生能力可能是未来治疗干预的有希望的目标.
相关概念视频
Tissue Renewal without Stem Cells
1.6K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
1.6K
iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K


